Join us for this Doctors for America program in which Dr. Madhav Thambisetty is a program participant. The program is about the FDA’s controversial approval of the Alzheimer’s drug, aducanumab (sold as Aduhelm by Biogen). In addition to Dr. Thambisetty, the program will include Caleb Alexander, MD and Holly Fernandez Lynch, JD, MBE. Drs. Alexander and Thambisetty are members of the FDA’s Peripheral and Central Nervous System Advisory Committee, which met in November 2020 to review the marketing application for aducanumab. Holly Fernandez Lynch is a bioethicist and professor of law.
